![Quiver Logo](/static/img/logo-icon.png)
![ENLV logo](https://quiver-logos.s3.us-east-2.amazonaws.com/enlv.png)
Enlivex Therapeutics Ltd. Ordinary Shares
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ENLV Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of ENLV by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ENLV's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to ENLV
Recent picks made for ENLV stock on CNBC
ETFs with the largest estimated holdings in ENLV
Flights by private jets registered to ENLV
![Quiver Logo](/static/img/logo-icon.png)